文献速递鼻科咽喉与嗓音

全局气道——一种新型的哮喘、过敏性鼻炎和慢性鼻窦炎标准测试(STARR-15)

Global airways â€" a novel Standard Tests for Asthma, allergic Rhinitis, and chronic Rhinosinusitis (STARR-15).
PubMed 文献 · Rhinology · 2022-01-01

研究旨在设计一个用于临床环境的全局气道疾病意识单一标准测试。2019年由鼻科和肺科医生生成条目池,对206例已知哮喘、慢性鼻窦炎(CRS)、过敏性鼻炎或其组合的患者进行施测,患者同时完成ACQ-5和SNOT-22。通过临床知识与数据驱动方法结合,从44个条目中识别出15个条目构成STARR-15问卷,包含过敏性鼻炎、CRS和哮喘三个子因子。

要点

  • STARR-15是首个全局气道问卷,用于评估上下气道症状患者。
  • 问卷包含过敏性鼻炎、CRS和哮喘三个子因子。
  • 未来需评估STARR-15的临床和心理测量学特性。

核心结论

  • STARR-15是首个全局气道问卷,用于检查上下气道症状患者,未来需评估其临床和心理测量学特性。

研究设计与样本

  • 2019年由鼻科和肺科医生基于文献、患者报告结局测量和临床经验生成条目池,对206例已知哮喘、CRS、过敏性鼻炎或其组合的患者施测。
  • 患者同时完成哮喘控制问卷(ACQ-5)和鼻窦结局测试(SNOT-22)。
  • 采用临床知识与数据驱动方法结合开发全局气道问卷。

主要发现

  • 平均ACQ评分在同时患三种疾病的患者中最高,而最高SNOT-22评分见于CRS合并哮喘的患者。
  • 对206例患者关于新全局气道问卷44个条目的应答分析后,识别出15个条目构成STARR-15问卷,包含过敏性鼻炎子因子、CRS子因子和哮喘子因子三个潜在域。

关键数值与推荐

  • STARR-15问卷由15个条目组成,具有三个潜在域:过敏性鼻炎子因子、CRS子因子和哮喘子因子。

临床怎么用

  • STARR-15可用于检查上下气道症状患者。

局限性

  • 未来需分析以评估STARR-15的临床和心理测量学特性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Global airway disease, with symptoms from both upper and lower airways, is a challenging problem for clinicians. Our goal is to design one single standard test for the awareness of global airway diseases to be used in clinical setting. MATERIAL AND METHODS: During 2019, rhinologists and pulmonologists generated a pool of items based on literature, patient-reported outcome measures and clinical experience. The items were administered to 206 patients with known asthma, CRS, allergic rhinitis, or a combination thereof. The patients also completed the Asthma Control Questionnaire (ACQ-5) and the Sino-Nasal Outcome Test (SNOT-22). Using a mix of clinical knowledge and data-driven methods a global airways questionnaire was developed. RESULTS: Mean ACQ score was highest in patients with all three, whereas the highest SNOT-22 score was observed in patients with CRS and asthma. After the development process, analysis of responses from 206 patients to 44 items on a new global airway’s questionnaire led to identification of 15 items that form the STARR-15 questionnaire with three underlying domains (an allergic rhinitis sub-factor, a CRS sub-factor and an asthma sub-factor). CONCLUSION: STARR-15 represents the first global airways questionnaire, to be used when examining patients with upper and lower airways symptoms. Future analyses are warranted to evaluate the clinical and psychometric properties of STARR-15.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Backer V, Aanaes K, Hansen S, et al. Global airways â€" a novel Standard Tests for Asthma, allergic Rhinitis, and chronic Rhinosinusitis (STARR-15). Rhinology. 2022. PMID: 35174371. doi:10.4193/Rhin21.195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。